Research & Innovation

Inventive talent

Felix Hoffmann, Wilhelm Roehl, Hans Andersag and Walter Kikuth, Gerhard Domagk, Otto Bayer, Hermann Schnell, Friedrich Bossert, Wulf Vater – researchers and scientists who made history. They were responsible for pioneering inventions that revolutionized medicine, chemistry and materials development: Aspirin®, Germanin®, Resochin®, sulfonamides, polyurethanes, Makrolon® and Adalat®.

Image: Hoffmann, Domagk, Schnell

Felix Hoffmann, Gerhard Domagk, Hermann Schnell

These outstanding scientists all had one thing in common: they established Bayer's reputation as an inventor company. Bayer retains a strong commitment to this tradition. The Group’s realignment enables us to focus on areas where innovation is the driving force: health care, nutrition and high-tech materials.

The wealth of knowledge that Bayer researchers have gained about people, animals, plants, materials and interdisciplinary technologies provides the basis for long-term, sustained growth. Research is essential capital for our future.

In 2007 Bayer invested a total of EUR 2,578 million in research and development. It is particularly important for us to continuously optimize our product portfolio and manufacturing processes, while at the same time developing new products aimed at strengthening our core businesses.

Learn more about the inventor company on a journey through the world of research (PDF 1.48 MB) at Bayer.

Bayer.com (Textversion)

Inventive talent